|
| 37563049 | Benefit-risk assessment of vaccines. | Vaccine | 2024 |
| 36410365 | Safety and reactogenicity of second booster doses for mRNA vaccines. | Lancet Respir Med | 2023 |
| 37777453 | Establishing vaccine pregnancy registries and active surveillance studies in low-and middle-income countries: Experience from an observational cohort surveillance project in The Gambia. | Vaccine | 2023 |
| 36435707 | Anaphylaxis: Revision of the Brighton collaboration case definition. | Vaccine | 2023 |
| 36496284 | Harmonized case definitions for endpoints in vaccine efficacy trials are needed. | Vaccine | 2023 |
| 33949661 | The Operational Feasibility of Vaccination Programs Targeting Influenza Risk Groups in the World Health Organization (WHO) African and South-East Asian Regions. | Clin Infect Dis | 2022 |
| 35680552 | Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services. | Clin Infect Dis | 2022 |
| 35821419 | Who to vaccinate first? A peek at decision-making in a pandemic. | Nature | 2022 |
| 35715351 | A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus. | Vaccine | 2022 |
| 35248422 | WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations. | Vaccine | 2022 |
| 35278358 | Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix? | Lancet Infect Dis | 2022 |
| 35180408 | Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review. | Lancet Glob Health | 2022 |
| 34902308 | Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability. | Lancet | 2022 |
| 35164990 | Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case. | Vaccine | 2022 |
| 34922639 | COVID-19 vaccine strategies must focus on severe disease and global equity. | Lancet | 2022 |
| 31060949 | Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response. | Vaccine | 2021 |
| 33836897 | COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER). | Vaccine | 2021 |
| 33634545 | Suitability of databases in the Asia-Pacific for collaborative monitoring of vaccine safety. | Pharmacoepidemiol Drug Saf | 2021 |
| 34389628 | Time for action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind. | BMJ Glob Health | 2021 |
| 33958395 | Ethical and policy considerations for COVID-19 vaccination modalities: delayed second dose, fractional dose, mixed vaccines. | BMJ Glob Health | 2021 |
| 34006021 | The use of a speaking book® to enhance vaccine knowledge among caregivers in The Gambia: A study using qualitative and quantitative methods. | BMJ Open | 2021 |
| 33168344 | The Brighton Collaboration standardized templates for collection of key information for benefit-risk assessment of vaccines by technology (BRAVATO; formerly V3SWG). | Vaccine | 2021 |
| 33217363 | Expecting the unexpected with COVID-19 vaccines. | Lancet Infect Dis | 2021 |
| 32212920 | Ethics of Conducting Clinical Research in an Outbreak Setting. | Annu Rev Virol | 2020 |
| 33070999 | Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines. | Vaccine | 2020 |
| 32747214 | The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines. | Vaccine | 2020 |
| 32684499 | Planning for COVID-19 vaccines safety surveillance. | Vaccine | 2020 |
| 32571717 | The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines. | Vaccine | 2020 |
| 32653276 | The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines. | Vaccine | 2020 |
| 32907759 | The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines. | Vaccine | 2020 |
| 32586597 | Group B streptococcal disease in the mother and newborn-A review. | Eur J Obstet Gynecol Reprod Biol | 2020 |
| 32448618 | Obstetrics risk Assessment: Evaluation of selection criteria for vaccine research studies in pregnant women. | Vaccine | 2020 |
| 32365191 | Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development. | J Infect Dis | 2020 |
| 30497831 | Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines. | Vaccine | 2019 |
| 31783983 | Neurodevelopmental delay: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. | Vaccine | 2019 |
| 31783981 | Neonatal seizures: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. | Vaccine | 2019 |
| 31783982 | Chorioamnionitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. | Vaccine | 2019 |
| 31783980 | Postpartum endometritis and infection following incomplete or complete abortion: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. | Vaccine | 2019 |
| 30252056 | Assessing feasibility of resources at health facilities in Uganda to diagnose pregnancy and neonatal outcomes. | Int Health | 2019 |
| 31439612 | Clinical trial data sharing: here's the challenge. | BMJ Open | 2019 |
| 31072733 | Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations. | Vaccine | 2019 |
| 31014963 | Immunization in pregnancy safety surveillance in low and middle-income countries- field performance and validation of novel case definitions. | Vaccine | 2019 |
| 31034019 | Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2017 Study. | JAMA Pediatr | 2019 |
| 30248195 | Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage. | J Clin Pharmacol | 2018 |
| 28703142 | New UK graduates' knowledge of training and service provision within restorative dentistry - a survey. | Br Dent J | 2017 |
| 28479177 | Immunization in pregnancy clinical research in low- and middle-income countries - Study design, regulatory and safety considerations. | Vaccine | 2017 |
| 29031696 | Safety assessment of immunization in pregnancy. | Vaccine | 2017 |
| 29150062 | Spontaneous abortion and ectopic pregnancy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. | Vaccine | 2017 |
| 29150061 | Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. | Vaccine | 2017 |
| 29150060 | Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. | Vaccine | 2017 |